Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area 2025-07-21 14:31
CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services 2025-07-21 10:54
MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation 2025-07-18 10:59
Co-PSMA trial: Recruitment successfully completed 2025-07-17 21:01
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate 2025-07-17 19:00
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam 2025-07-17 13:56
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer 2025-07-16 20:00
The 2025 Mammoth International Contest on Omics Sciences - Young Scientists Track Now Open for Hot Registration! 2025-07-16 18:12
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors 2025-07-16 10:32
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer 2025-07-16 09:47
ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO 2025-07-16 09:00
PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test 2025-07-16 08:54
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company 2025-07-15 19:30
AXA and China Biotech Services Sign Memorandum of Understanding 2025-07-15 15:23
Divamics' AI and Molecular Dynamics Platform Powers Breakthroughs in Metabolic Disease Drug Discovery for Partners 2025-07-15 07:31
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity 2025-07-15 07:00
LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER 2025-07-15 02:56
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform 2025-07-14 15:38
Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot 2025-07-14 15:00
1 29 30 31 32 33 525